Form 483

Private Label Partners, Inc. Form 483, 2012-03-14

FDA issued a Form 483 to Private Label Partners, Inc. on 2012-03-14 with 8 public-safe observations.

483· Form 483 issued8 observations

Private Label Partners, Inc. · Santa Ana, United States · Issued March 14, 2012

Overview

  • 8 public-safe observations are available for this inspection.
  • 7 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

14 Mar 2012
21 CFR 211.100(a)

Absence of Written Procedures

Cited by Thao T Kwan

14 Mar 2012
21 CFR 211.100(a)

Changes to Procedures Not Reviewed, Approved

Cited by Thao T Kwan

14 Mar 2012
21 CFR 211.110(a)

Control procedures fail to include the following

Cited by Thao T Kwan

14 Mar 2012
21 CFR 211.160(b)

Scientifically sound laboratory controls

Cited by Thao T Kwan

14 Mar 2012
21 CFR 211.165(a)

Testing and release for distribution

Cited by Thao T Kwan

Inspected site

PLPrivate Label Partners, Inc.Santa Ana, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.100(a)Cited across public-safe Form 483 observations2x
21 CFR 211.110(a)Cited across public-safe Form 483 observations1x
21 CFR 211.160(b)Cited across public-safe Form 483 observations1x
21 CFR 211.165(a)Cited across public-safe Form 483 observations1x
21 CFR 211.166(a)Cited across public-safe Form 483 observations1x
21 CFR 211.182Cited across public-safe Form 483 observations1x
21 CFR 211.188(b)(10)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 8 observations

The source PDF and every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere